HIGHLIGHTS
- who: Dana Hamam from the Cancer Research Program, McGill University Health Centre-Research Institute, Decarie Boulevard, Montreal H A , QC, Canada have published the Article: Transfer of malignant trait to BRCA1 deficient human fibroblasts following exposure to serum of cancer patients, in the Journal: (JOURNAL)
- what: The aims of the investigations were to determine the oncogenic potential of cancer patients' sera on BRCA1KO human fibroblasts, to characterize their differentiation following serum treatments and evaluate their phenotypes, and to determine their receptiveness to integrate serum-carried factors, such as exosomes. For this study, the authors designed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.